Summary
A bioRxiv preprint reports that age-related bone loss in mice coincided with impaired glycolysis in bone tissue. Caloric restriction and osteoblast-specific genetic interventions that enhanced glycolysis improved bone outcomes in the mice.
A bioRxiv preprint reports that aged mice had lower bone-forming activity alongside impaired glycolysis in bone tissue, the authors say. Glycolysis is the series of chemical reactions through which cells break down glucose. In the study, long-term caloric restriction prevented age-related loss of trabecular bone, while two osteoblast-specific genetic interventions that enhanced glycolysis improved bone measures in aged mice.
What the researchers found
The team used stable-isotope tracing in living mice to study metabolism in bone. They report that declining bone formation with age was coupled to reduced glycolysis within bone tissue. Levels of key glycolysis enzymes were lower in aged bone, even as transcriptomic analysis found increased expression of genes involved in glycolysis. The authors interpret that gene-expression rise as a compensatory response to impaired activity.
Osteoblasts are cells that build new bone. The researchers genetically enhanced glycolysis specifically in these cells by increasing either HIF1α or PFKFB3, a rate-limiting enzyme in glycolysis. Both approaches significantly improved osteoblast function and increased bone mass in aged mice, according to the abstract.
The study also reports that long-term caloric restriction prevented age-related loss of trabecular bone, the porous bone found inside structures such as vertebrae and the ends of long bones. This intervention and the genetic experiments are distinct approaches; the abstract does not describe caloric restriction as an osteoblast-specific treatment.
What the findings mean
The results point to metabolism within bone-forming cells as a possible contributor to age-related bone decline, rather than treating bone loss only as a consequence of broader changes elsewhere in the body. The genetic interventions provide evidence in mice that increasing glycolysis in osteoblasts can improve their function and raise bone mass.
The work is a preprint, and its evidence comes from mice. It therefore identifies a biological pathway for further study, not an established treatment for age-related bone loss in people. Whether the same metabolic changes are important in human bone aging, and whether they can be safely targeted, remains to be determined.